MGNet Consortium Updates | The Myasthenia Gravis Rare Disease Network

Skip to main content

Search

Join Our Contact Registry

Header Social Media

Main navigation

Our Research
Patients and Families
Researchers and Clinicians
Early Stage Investigators
News and Events
- Latest News
- Newsletters
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

Mon, 08/15/2022 - 12:48

Summer Issue

Document

Attachment	Size
MGNet_Newsletters_Summer-2022.pdf	890.81 KB

Myasthenia Gravis Rare Disease Network

Image

The first page of the MGNet Summer 2022 newsletter

Footer menu

Web Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Myasthenia Gravis Rare Disease Network (MGNet) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). MGNet is funded under grant number U54NS115054 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). This website is hosted by the network's Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the MGNet administrative coordinating center at George Washington University and does not necessarily represent the official views of the NIH.

social media